Group Executive Health Economics and Research,
Diabetes Australia
Dr Amber Willink is currently a Group Executive, Health Economics and Research Lead at Diabetes Australia. Dr Willink brings experience from previous roles at Bupa and University of Sydney. With leadership experience across public, private, and not-for-profit sectors, she specialises in translating complex data and insights into clear, actionable strategies that improve performance and outcomes. Dr Willink has a robust skill set that includes Global Health, Epidemiology, Health Economics, Policy Analysis, Health Policy and more.